<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4465</id>
  <title>T3D4411</title>
  <common-name>L-Proline</common-name>
  <description>L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It is an essential component of collagen and is important for proper functioning of joints and tendons.</description>
  <cas>147-85-3</cas>
  <pubchem-id>145742</pubchem-id>
  <chemical-formula>C5H9NO2</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point>221 dec°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility>1.62E+005 mg/L (at 25°C)</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity>Glycogenic, by L-Proline oxidase in the kidney, it is ring-opened and is oxidized to form L-Glutamic acid. L-Ornithine and L-Glutamic acid are converted to L-Proline via L-Glutamic acid-gamma-semialdehyde. It is contained abundantly in collagen, and is intimately involved in the function of arthrosis and chordae.</mechanism-of-toxicity>
  <metabolism>Hepatic</metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>L-Proline is extremely important for the proper functioning of joints and tendons and also helps maintain and strengthen heart muscles.</use-source>
  <min-risk-level nil="true"/>
  <health-effects>Chronically high levels of proline are associated with at least 5 inborn errors of metabolism including: Hyperprolinemia Type I, Hyperprolinemia Type II, Iminoglycinuria, Prolinemia Type II and Pyruvate carboxylase deficiency.</health-effects>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:51:05Z</created-at>
  <updated-at type="dateTime">2026-05-14T16:31:22Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>L-Proline</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C00148</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>17203</chebi-id>
  <biocyc-id>PRO</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB00172</drugbank-id>
  <pdb-id>PRO</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>OC(=O)[C@@H]1CCCN1</moldb-smiles>
  <moldb-formula>C5H9NO2</moldb-formula>
  <moldb-inchi>InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1</moldb-inchi>
  <moldb-inchikey>ONIBWKKTOPOVIA-BYPYZUCNSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">115.1305</moldb-average-mass>
  <moldb-mono-mass type="decimal">115.063328537</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>-2.54</logp>
  <hmdb-id>HMDB00162</hmdb-id>
  <chembl-id>CHEMBL54922</chembl-id>
  <chemspider-id>128566</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Richard I. Leavitt, &amp;#8220;L-Proline production from algae.&amp;#8221; U.S. Patent US4383039, issued October, 1968.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003371</chemdb-id>
  <dsstox-id>DTXSID5044021</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00074201</susdat-id>
  <iupac>(2S)-pyrrolidine-2-carboxylic acid</iupac>
  <moldb-polar-surface-area>49.33</moldb-polar-surface-area>
  <moldb-refractivity>28.064299999999996</moldb-refractivity>
  <moldb-polarizability>11.50403298353395</moldb-polarizability>
  <moldb-rotatable-bond-count>1</moldb-rotatable-bond-count>
  <moldb-acceptor-count>3</moldb-acceptor-count>
  <moldb-donor-count>2</moldb-donor-count>
  <moldb-pka-strongest-acidic>1.9406707712827913</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>11.332026115136207</moldb-pka-strongest-basic>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>1</moldb-number-of-rings>
  <moldb-alogps-logp>-2.71</moldb-alogps-logp>
  <moldb-alogps-logs>0.50</moldb-alogps-logs>
  <moldb-alogps-solubility>3.65e+02 g/l</moldb-alogps-solubility>
</compound>
